How McEwen MUX balances short term and long term focus Q1 2026 Earnings Beat Estimates What BitcoinInfra BIXIU disclosed about liquidity position BIXIU Earnings BitcoinInfra Reports No Revenue JB Hunt JBHT Stock Days To Cover Institutional Demand 20260420 Digital Realty Trust DLR AIDX 2020 Biolabs highlights rising clinical test adoption as core growth driver in latest quarterly earnings LSPD Lightspeed notches small Q1 2026 earnings beat shares climb over two percent on warm investor reception DBI Designer shares drop 449 percent even as Q1 2026 EPS beats analyst consensus estimates by 38 percent SBCF Seacoast reports 54 percent Q1 2026 EPS beat with shares dipping slightly in todays session SP 500 Edges Higher as Healthcare and Tech Lead Comms Stands Alone Paul Tudor Jones Says Kevin Warsh No Chance of Cutting Fed Rates Market Implications IREN Shares Surge on 16 Billion Dell Partnership for AI Infrastructure Broad AILed Selloff Hits Wall Street as Chinas DeepSeek Spurs Rout Corn Futures Decline in LateWeek Trade as Market Consolidates Fed Rate Hike Expectations for 2026 Key Market Factors Investors Should Watch SU Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Strength SEI Q1 2026 Earnings EPS Surges Past Estimates with 6598 Surprise TPG Q1 2026 Earnings EPS Beats Estimates by 14 Stock Edges Lower Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue CooperStandard Holdings CPS Q1 2026 Earnings EPS Falls Short of Expectations Shares Rally Barinthus Biotherapeutics BRNS Pulls Back to Support as Sector Headwinds Persist Sarepta Therapeutics SRPT Shows Modest Uptick Amid Key Technical Levels Skillsoft Corp SKIL Rallies 237 as Shares Test Key Resistance Area Health In Tech Inc HIT Slides 357 as Stock Tests Key Support Levels Real Messenger Warrants RMSGW Hover at Penny Level Amidst Flat Trading Snowflake Boosts Annual Product Revenue Forecast as Enterprise AI Adoption Accelerates LTC Properties Inc Q1 2026 Earnings EPS Miss Disappoints Despite Resilient REIT Operations Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds